Cassava Sciences | PTIE - Capitale Di Prestito





Capitale Di Prestito Cambiamento Data
Abbott USD 29.64B 19.74B 2026-03
Amgen USD 51.86B 27M 2026-06
Biogen USD 7.29B 1B 2026-06
Cara Therapeutics USD 0 0 2025-03
Cassava Sciences USD 0 0 2024-12
Eisai JPY 184.6B 49.83B 2026-06
Eli Lilly USD 47.86B 8.49B 2026-06
Geron USD 120.13M 298K 2026-06
J&J USD 37.34B 183M 2026-06
Merck USD 51.08B 4.41B 2026-06
Novartis USD 37.49B 42M 2026-06
Novavax USD 246.3M 200K 2025-12
Pfizer USD 60.5B 70M 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06